Stockreport

Pyxis Oncology to Participate in Upcoming Investor Conferences

Pyxis Oncology, Inc.  (PYXS) 
PDF BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat [Read more]